371 related articles for article (PubMed ID: 9423792)
1. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
[TBL] [Abstract][Full Text] [Related]
2. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
4. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
6. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
7. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock.
Hartemink KJ; Hack CE; Groeneveld AB
J Clin Pathol; 2010 Nov; 63(11):1021-6. PubMed ID: 20870661
[TBL] [Abstract][Full Text] [Related]
8. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
Nanninga PB; van Teunenbroek A; Veenhof CH; Büller HR; ten Cate JW
Thromb Haemost; 1990 Nov; 64(3):361-4. PubMed ID: 1710832
[TBL] [Abstract][Full Text] [Related]
10. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
11. Early procoagulant shift in the bronchoalveolar compartment of patients with secondary peritonitis.
van Till JW; Levi M; Bresser P; Schultz MJ; Gouma DJ; Boermeester MA
J Infect Dis; 2006 Nov; 194(9):1331-9. PubMed ID: 17041861
[TBL] [Abstract][Full Text] [Related]
12. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
13. [Abnormalities in coagulation and fibrinolysis in septic shock with purpura].
Sánchez Miralles A; Reig Sáenz R; Marco Vera P; Muñoz Pérez F; Alvarez Sánchez B; Sebastián Muñoz I
An Esp Pediatr; 2002 Feb; 56(2):99-103. PubMed ID: 11827669
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients.
van der Heijden M; van Nieuw Amerongen GP; Koolwijk P; van Hinsbergh VW; Groeneveld AB
Thorax; 2008 Oct; 63(10):903-9. PubMed ID: 18559364
[TBL] [Abstract][Full Text] [Related]
15. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
16. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
17. [Application of continuous veno-venous hemofiltration in patients with acute respiratory distress syndrome].
Jin ZC; Yu ZX; Ji MS; Zhou H
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2274-7. PubMed ID: 19087678
[TBL] [Abstract][Full Text] [Related]
18. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
[TBL] [Abstract][Full Text] [Related]
19. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
